| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $812.1M | +8.4% |
| Cost of Revenue | $508.9M | +12.8% |
| R&D Expense | $74.4M | -50.7% |
| SG&A Expense | $203.4M | -30.9% |
| Operating Income | -$24.4M | +90.3% |
| Pre-tax Income | -$181.2M | +34.4% |
| Income Tax | $15.6M | -5.1% |
| Net Income | -$128.4M | +57.5% |
| EPS (Basic) | -$2.14 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.5M | -39.8% |
| Accounts Receivable | $79.5M | +34.3% |
| Current Assets | $303.4M | -27.7% |
| Total Assets | $1.21B | +15.6% |
| Current Liabilities | $74.9M | -41.5% |
| Total Liabilities | $468.4M | +67.5% |
| Stockholders' Equity | $559.7M | +1.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.6M | +123.9% |
| Capital Expenditures | $20.2M | -9.9% |
| Investing Cash Flow | -$412.7M | -55.5% |
| Financing Cash Flow | $289.1M | -34.0% |
| Free Cash Flow | -$10.6M | +83.0% |
| -210.1% |
| EPS (Diluted) | -$2.14 | -210.1% |